- £3.25bn
- £3.17bn
- £1.45bn
- 99
- 36
- 54
- 71
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,632 | 1,336 | 1,163 | 1,327 | 1,449 |
Cost of Revenue | |||||
Gross Profit | 914 | 736 | 676 | 751 | 838 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,343 | 1,355 | 797 | 1,155 | 1,273 |
Operating Profit | 289 | -18.9 | 366 | 173 | 176 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 259 | -4.1 | 374 | 152 | 186 |
Provision for Income Taxes | |||||
Net Income After Taxes | 234 | -17 | 336 | 115 | 145 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 234 | -17 | 347 | 402 | 145 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 234 | -17 | 347 | 402 | 145 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.64 | 1.42 | 1.21 | 1.26 | 1.89 |
Dividends per Share |